tremelimumab,savolitinib,durvalumab
hutchmed,pfizer,astrazeneca,orpathys
['savolitinib', 'calypso', 'tremelimumab', 'renal,(-adrenal)', 'durvalumab']
#calypso: a three-arm randomized phase ii study of durvalumab alone or with savolitinib or tremelimumab in previously treated advanced clear cell #renalcancer. presentation by . #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology